CURE bleeding criteria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

CURE Clinical Trials:

The Clopidogrel In Unstable Angina To Prevent Recurrent Events Trial

Clopidogrel In Unstable Angina To Prevent Recurrent Ischemic Events^[1]

“

Major Bleeding

Life-threatening (fatal, intracranial, requiring surgical intervention, results in substantial hypotension requiring the use of intravenous inotropic agents) Hemoglobin decrease ≥5 g/dL or required ≥4 U of blood Other major bleeding Transfusion of 2–3 U, intraocular

Minor

Led to discontinuation of study drug

”

References

↑ Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S (2006). “Adverse impact of bleeding on prognosis in patients with acute coronary syndromes”. Circulation. 114 (8): 774–82. doi:10.1161/CIRCULATIONAHA.106.612812. PMID 16908769.

Template:WH Template:WS

[pmid16908769-1] Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S (2006). “Adverse impact of bleeding on prognosis in patients with acute coronary syndromes”. Circulation. 114 (8): 774–82. doi:10.1161/CIRCULATIONAHA.106.612812. PMID 16908769.

[1]

CURE bleeding criteria

CURE Clinical Trials:

References

Looking for the patient version?